Expression of the p53 inhibitors MDM2 and MDM4 as outcome predictor in muscle-invasive bladder cancer

Aim: To evaluate the prognostic role of the p53-upstream inhibitors MDM2, MDM4 and its splice variant MDM4-S in patients undergoing radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC). Materials and Methods: mRNA Expression levels of MDM2, MDM4 and MDM4-S were assessed by quantitative...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kriegmair, Maximilian (VerfasserIn) , Steidler, Annette (VerfasserIn) , Weis, Cleo-Aron Thias (VerfasserIn) , Erben, Philipp (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: October 2016
In: Anticancer research
Year: 2016, Jahrgang: 36, Heft: 10, Pages: 5205-5213
ISSN:1791-7530
DOI:undefined
Online-Zugang:Verlag, Volltext: https://doi.org/undefined
Verlag, Volltext: http://ar.iiarjournals.org/content/36/10/5205
Volltext
Verfasserangaben:Maximilian Christian Kriegmair, Matthias Balk, Ralph Wirtz, Annette Steidler, Cleo-Aron Weis, Johannes Breyer, Arndt Hartmann, Christian Bolenz and Philipp Erben

MARC

LEADER 00000caa a2200000 c 4500
001 1668936372
003 DE-627
005 20220816190427.0
007 cr uuu---uuuuu
008 190710s2016 xx |||||o 00| ||eng c
035 |a (DE-627)1668936372 
035 |a (DE-599)KXP1668936372 
035 |a (OCoLC)1341233387 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kriegmair, Maximilian  |d 1987-  |e VerfasserIn  |0 (DE-588)1049742745  |0 (DE-627)782573347  |0 (DE-576)403726840  |4 aut 
245 1 0 |a Expression of the p53 inhibitors MDM2 and MDM4 as outcome predictor in muscle-invasive bladder cancer  |c Maximilian Christian Kriegmair, Matthias Balk, Ralph Wirtz, Annette Steidler, Cleo-Aron Weis, Johannes Breyer, Arndt Hartmann, Christian Bolenz and Philipp Erben 
264 1 |c October 2016 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.07.2019 
520 |a Aim: To evaluate the prognostic role of the p53-upstream inhibitors MDM2, MDM4 and its splice variant MDM4-S in patients undergoing radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC). Materials and Methods: mRNA Expression levels of MDM2, MDM4 and MDM4-S were assessed by quantitative real-time polymerase chain reaction (qRT-PCR) in 75 RC samples. Logistic regression analyses identified predictors of recurrence-free (RFS) and cancer-specific survival (CSS). Results: High expression was found in 42% (MDM2), 27% (MDMD4) and 91% (MDM4-S) of tumor specimens. Increased MDM2 expression was significantly associated with higher tumor stage (p=0.05) and lymphovascular invasion (LVI) (p=0.041). In the univariate analysis, low MDM4 expression (hazard ratio (HR)=5.93; p=0.002; HR=3.00; p=0.047), but not MDM2 (HR=1.63; p=0.222; HR=1.59; p=0.27), were associated with RFS and CSS. In the multivariate analysis, the combination of low MDM4 and high MDM2 was significant for RFS and CSS (HR=14.9; p=0.001; HR=5.63; p=0.019). Conclusion: The combination of MDM2 and MDM4 expression is an independent predictor in patients undergoing RC for MIBC. 
650 4 |a bladder cancer 
650 4 |a HDMX 
650 4 |a marker 
650 4 |a MDM2 
650 4 |a prognosis 
700 1 |a Steidler, Annette  |d 1965-  |e VerfasserIn  |0 (DE-588)1038074843  |0 (DE-627)756633761  |0 (DE-576)392092263  |4 aut 
700 1 |a Weis, Cleo-Aron Thias  |d 1985-  |e VerfasserIn  |0 (DE-588)1062803752  |0 (DE-627)806961198  |0 (DE-576)42022730X  |4 aut 
700 1 |a Erben, Philipp  |d 1973-  |e VerfasserIn  |0 (DE-588)128501014  |0 (DE-627)373920997  |0 (DE-576)297181661  |4 aut 
773 0 8 |i Enthalten in  |t Anticancer research  |d Kapandriti, Attiki, Greece : International Institute of Anticancer Research, 2004  |g 36(2016), 10, Seite 5205-5213  |h Online-Ressource  |w (DE-627)387478493  |w (DE-600)2145376-7  |w (DE-576)358408717  |x 1791-7530  |7 nnas  |a Expression of the p53 inhibitors MDM2 and MDM4 as outcome predictor in muscle-invasive bladder cancer 
773 1 8 |g volume:36  |g year:2016  |g number:10  |g pages:5205-5213  |g extent:9  |a Expression of the p53 inhibitors MDM2 and MDM4 as outcome predictor in muscle-invasive bladder cancer 
856 4 0 |u https://doi.org/undefined  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://ar.iiarjournals.org/content/36/10/5205  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190710 
993 |a Article 
994 |a 2016 
998 |g 128501014  |a Erben, Philipp  |m 128501014:Erben, Philipp  |d 60000  |d 63100  |e 60000PE128501014  |e 63100PE128501014  |k 0/60000/  |k 1/60000/63100/  |p 9  |y j 
998 |g 1062803752  |a Weis, Cleo-Aron Thias  |m 1062803752:Weis, Cleo-Aron Thias  |d 60000  |d 63400  |e 60000PW1062803752  |e 63400PW1062803752  |k 0/60000/  |k 1/60000/63400/  |p 5 
998 |g 1038074843  |a Steidler, Annette  |m 1038074843:Steidler, Annette  |d 60000  |d 63100  |e 60000PS1038074843  |e 63100PS1038074843  |k 0/60000/  |k 1/60000/63100/  |p 4 
998 |g 1049742745  |a Kriegmair, Maximilian  |m 1049742745:Kriegmair, Maximilian  |d 60000  |d 63100  |e 60000PK1049742745  |e 63100PK1049742745  |k 0/60000/  |k 1/60000/63100/  |p 1  |x j 
999 |a KXP-PPN1668936372  |e 3492477984 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Kriegmair, Maximilian","role":"aut","given":"Maximilian","family":"Kriegmair"},{"family":"Steidler","role":"aut","given":"Annette","display":"Steidler, Annette"},{"family":"Weis","role":"aut","given":"Cleo-Aron Thias","display":"Weis, Cleo-Aron Thias"},{"given":"Philipp","role":"aut","display":"Erben, Philipp","family":"Erben"}],"name":{"displayForm":["Maximilian Christian Kriegmair, Matthias Balk, Ralph Wirtz, Annette Steidler, Cleo-Aron Weis, Johannes Breyer, Arndt Hartmann, Christian Bolenz and Philipp Erben"]},"physDesc":[{"extent":"9 S."}],"id":{"eki":["1668936372"]},"relHost":[{"part":{"volume":"36","text":"36(2016), 10, Seite 5205-5213","year":"2016","extent":"9","pages":"5205-5213","issue":"10"},"language":["eng"],"title":[{"title_sort":"Anticancer research","title":"Anticancer research","subtitle":"international journal of cancer research and treatment"}],"pubHistory":["Nachgewiesen 24.2004 -"],"name":{"displayForm":["International Institute of Anticancer Research"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"387478493","origin":[{"publisher":"International Institute of Anticancer Research","dateIssuedDisp":"2004-","dateIssuedKey":"2004","publisherPlace":"Kapandriti, Attiki, Greece"}],"note":["Gesehen am 26.02.13"],"disp":"Expression of the p53 inhibitors MDM2 and MDM4 as outcome predictor in muscle-invasive bladder cancerAnticancer research","id":{"zdb":["2145376-7"],"issn":["1791-7530"],"eki":["387478493"]},"physDesc":[{"extent":"Online-Ressource"}]}],"note":["Gesehen am 10.07.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"October 2016"}],"recId":"1668936372","title":[{"title_sort":"Expression of the p53 inhibitors MDM2 and MDM4 as outcome predictor in muscle-invasive bladder cancer","title":"Expression of the p53 inhibitors MDM2 and MDM4 as outcome predictor in muscle-invasive bladder cancer"}],"language":["eng"]} 
SRT |a KRIEGMAIRMEXPRESSION2016